20 articles
New Nature studies reveal the thymus remains a critical organ in adult health, predicting mortality, cardiovascular, and cancer outcomes.
Scientists used three Yamanaka factors to help mouse heart muscle cells complete division, reducing scar tissue after heart attacks.
A stem cell therapy for geographic atrophy showed sustained vision gains and retinal repair three years after a single injection in a Phase 1/2a trial.
Cambridge researchers found a gene network that shuts off nerve repair — and an existing hormone drug that reactivates it.
New research shows senescent cells play a vital healing role in youth — and losing this response may explain why wounds heal slower with age.
A new perspective outlines how stem cells, bioprinted organs, and cross-species genes could replace — not just repair — aging biology.
CellProthera's ProtheraCytes targets heart repair post-myocardial infarction, aiming to prevent heart failure before damage becomes irreversible.
Tumor-infiltrating lymphocyte therapies are emerging as a powerful cancer treatment. Here's what the science says and why it matters for longevity.
A new MIT-led therapy uses mRNA nanoparticles to rewire immune cells from within, achieving complete tumor regression in most treated mice.
Ossium Health is banking donor bone marrow for on-demand transplant, targeting immune aging as a future healthspan intervention.
ROKIT Healthcare reports zero recurrence and sensory recovery in 2-year follow-up using AI-guided regenerative tissue reconstruction.
A 3D neural microtissue therapy restored dopamine signaling in 48 hours and motor function in 13 weeks in preclinical Parkinson's models.
MIT researchers discover cysteine activates immune cells that boost intestinal stem cells, opening doors to nutrition-based gut therapies.
Researchers discovered how to restore tumor-killing power in worn-out immune cells by switching off just two genes.
Clearing zombie cells then restoring stem cell activity produced far greater lifespan gains than either approach alone.
Aspen Neuroscience's stem cell therapy restored dopamine neurons in Parkinson's patients, adding ~2 hours of controlled movement daily.
Sana Biotechnology and Mayo Clinic are advancing SC451, a cell therapy that may restore natural insulin production without immunosuppression.
ROKIT Healthcare reports zero tumor recurrence and improved healing using AI-guided fat tissue bioprinting to reconstruct skin cancer excision sites.
A novel dual CAR T-cell approach eliminated blocking antibodies in highly sensitized patients, enabling kidney transplants previously considered impossible.
Engineered heart muscle patches from stem cells thickened weakened heart walls and improved pumping ability in a small human trial.
